特布他林联合盐酸氨溴索雾化吸入治疗哮喘的疗效分析

The efficacy of terbutaline combined with ambroxol hydrochloride in the treatment of asthma

目的探讨特布他林联合盐酸氨溴索对于哮喘的治疗效果,对其临床应用进行评价。方法收集在本院治疗的84例哮喘患者,随机分为两组。对照组给予特布他林,观察组患者在对照组的基础上给予盐酸氨溴索雾化,对两组患者的有效率及临床症状消失时间进行比较。结果观察组的有效率95.2%(40/42)高于对照组78.5%(33/42),观察组患者喘息、咳嗽及胸闷等临床症状的消失时间均短于对照组(P<0.05);两组患者均没有明显的不良反应,仅出现头晕、恶心等症状。结论特布他林联合盐酸氨溴索对于哮喘患者的治疗效果较好,安全可靠,其能够提高患者的治疗有效率,促进临床症状的消失,可以在临床上推广应用。

Objective To investigate the efficacy of terbutaline combined with ambroxol hydrochloride in the treatment of asthma and evaluate its clinical application, Methods Eighty-four patients with asthma treated in our hospital were randomly divided into two groups. The control group was given terbutaline and the observation group was given am- broxol hydrochloride atomization on the basis of control group. The effective rate and the disappearance time of clinical symptoms of the two groups were compared. Results The observation group had an effective rate of 95.2% （40/42）, which was higher than the 78.5% （33/42） of the control group. The disappearance time of clinical symptoms such as wheezing, coughing and chest tightness of the observation group were shorter than those of the control group （P 〈 0.05）. No significant adverse reaction was observed in either group and only dizziness and nausea appeared. Conclusion Terbutaline combined with ambroxol hydrochloride is fairly effective, safe and reliable and can improve the treatment effective rate and accelerate the disappearance of clinical symptoms in the treatment of patients with asthma, thus can be wildly applied in clinical practice.